MAPS 2025 Decoded: The Medical Affairs Playbook for Successful Drug Launches
At the MAPS Americas 2025 conference in New Orleans, one of the pivotal discussions centered around preparing for drug launches in the current pharmaceutical landscape. While many important topics were covered, a critical element that was notably missing from the discussion was the need for a strategic north star—a guiding philosophy that ensures all tactical…...
Read MoreTop Stories
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Biopharma Trends 2025: 3 Things to Know Right Now
The global business climate is ever-evolving, and 2025 looks...
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
Filter
Bringing New Devices to Market under the EU MDR
With the MDR coming into effect, the manufacturers should plan and construct their strategy to...
Pharma, Physician, and Patient Pain Points Regarding Clinical Trials
Pharma, physicians, and patients consistently face challenges related to clinical trials. Here's a quick look...
Clinical Trial Summaries – What Are They and Why Do They Matter for Pharma?
A majority of patients feel lay summaries for clinical trials are very important and won’t...
How Can Preprints Drive Trust in Science?
By tagging preprints with various indicators, badges may represent quality, rigor, and scope. In doing...
How to Incorporate and Drive Equity, Diversity, and Inclusion in Medical Communications and Publications
A roadmap on how to drive advocacy for EDI in medical communications and publications and...
Using Digital Enhancements to Maximize Engagement: How Are Pharma and Publishers Embracing Digital?
Best practices to implement digital enhancements and measure effectiveness...